跳至主要内容
临床试验/CTRI/2016/09/007275
CTRI/2016/09/007275已完成2 期

Evaluation of the Keratex Oil for hair growth, hair density and overall improvement inhair & scalp condition in healthy human subjects

Dabur India Ltd0 个研究点目标入组 76 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and female subjectsâ?? in general good health.
  • Subjects in the age group 18-55 years (both the ages
  • inclusive).
  • Subjects willing to give a written informed consent and
  • agree to come for a regular follow up visit.
  • Female and Male Subjects falling under Grade 3 - Grade 8 of hair loss severity grade evaluated as per standard photo numeric 10 point scale
  • Subjects willing to abide by and comply with the study
  • Subjects who have not participated in a similar
  • investigation in the past two weeks.
  • Subjects complaining of hair fall and damage.
  • Healthy volunteers with no known allergy as established
  • by medical history.
  • Subjects who are not on crash dieting.
  • Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration.
  • Literate subjects only.

排除标准

  • Subjects who are undergoing hair growth treatment within 3 months before screening into the study.
  • Subjects having any active scalp disease which may interfere in the study.
  • Subjects who have treatments of cancer chemotherapy last 6 months before starting study or have a plan to do treatments of them during study terms.
  • Subjects who have history of alcoholism and/ or
  • psychiatric disorder including trichotillomania.
  • Subjects who have had hair transplant.
  • Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia.
  • A known history or present condition of allergic
  • response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
  • Subjects on oral medications which will compromise the study.
  • Subjects who are pregnant or lactating or nursing as established with medical history.
  • Chronic illness which may influence the cutaneous state.
  • Subjects participating in other similar cosmetic or therapeutic trial within last two weeks
  • Subject having history of migraine headache.

研究者

相似试验